lobbying_activities: 3009245

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3009245	17304f11-a333-4519-b9e9-74e57c94f487	Q2	CONSUMER HEALTHCARE PRODUCTS ASSOCIATION	29403	CONSUMER HEALTHCARE PRODUCTS ASSOCIATION	2023	second_quarter	PHA	OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Proposed rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act -- not yet introduced. FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	171093		0	0	2023-07-18T10:17:34-04:00